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Abstract: Static and dynamic hyperinﬂ  ation is an important factor of exertional dyspnea in 
patients with severe COPD. This proof-of-concept intervention trial sought to study whether 
laughter can reduce hyperinﬂ  ation through repetitive expiratory efforts in patients with severe 
COPD. For small groups of patients with severe COPD (n = 19) and healthy controls (n = 10) 
Pello the clown performed a humor intervention triggering regular laughter. Plethysmography 
was done before and up to 24 hours after intervention. Laughing and smiling were quantiﬁ  ed 
with video-analysis. Real-time breathing pattern was assessed with the LifeShirt™, and the 
psychological impact of the intervention was monitored with self-administered questionnaires. 
The intervention led to a reduction of TLC in COPD (p = 0.04), but not in controls (p = 0.9). TLC 
reduction was due to a decline of the residual volume. Four (22 [CI 95% 7 to 46] %) patients 
were  10% responders. The frequency of smiling and TLC at baseline were independent 
predictors of TLC response. The humor intervention improved cheerfulness, but not seriousness 
nor bad mood. In conclusion, smiling induced by a humor intervention was able to reduce 
hyperinﬂ  ation in patients with severe COPD. A smiling-derived breathing technique might 
complement pursed-lips breathing in patients with symptomatic obstruction.
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Introduction
Chronic obstructive lung disease (COPD) is characterized by static and dynamic air 
trapping leading to hyperinﬂ  ation (Pauwels et al 2001). Hyperinﬂ  ation with consecu-
tive ﬂ  attening of the diaphragm increases the respiratory effort and is an important 
mechanism responsible for dyspnoea in these patients. Different treatment strategies 
for COPD aim to reduce lung hyperinﬂ  ation. Along these lines, the reduction of 
hyperinﬂ  ation is the main effect of bronchodilators leading to symptomatic relief 
in patients with COPD. They improve the emptying of air in the distended terminal 
airspaces by dilating the bronchi. Lung volume reduction surgery is another example 
of the beneﬁ  t for patients when reducing hyperinﬂ  ation. It has not yet been studied 
whether laughter would be able to reduce lung volumes in patients with COPD. It 
could be speculated that the repetitive expiratory efforts would be able to do so. On the 
other hand, the increased minute ventilation during laughter could increase dynamic 
hyperinﬂ  ation (O’Donnell et al 2001). Although bronchial hyperresponsiveness is not 
a typical feature of COPD, it can be observed in a signiﬁ  cant proportion of patients 
with COPD (Brutsche et al 2006). The presence of bronchial hyperresponsiveness 
might lead to laughter-induced worsening of bronchial obstruction comparable to 
the situation in patients with asthma. Laughter is a recognized trigger for asthma 
attacks (Saraﬁ  no and Dillon 1998). Liangas and colleagues (2004) found that 44 of 
105 patients reported laughter-induced asthma. Laughter-induced asthma was associ-
ated with poor asthma control in their study. It can be postulated that laughter might 
be harmful in combination with poorly controlled bronchial hyperresponsiveness International Journal of COPD 2008:3(1) 186
Brutsche et al
(Herxheimer 1978). On the other hand, watching a humor-
ous ﬁ  lm led to a signiﬁ  cant reduction of bronchial hyper-
responsiveness to methacholine in a controlled trial in 20 
asthmatic patients (Kimata 2004).
Filipelli and colleagues (2001) investigated the effects of 
ﬁ  ts of laughter in 11 healthy controls. They concluded that 
all ﬁ  ts of laughter were characterized by a sudden occurrence 
of repetitive expiratory efforts resulting in an immediate sig-
niﬁ  cant reduction of the functional residual capacity (FRC). 
Laughter was associated with excessively high intra-thoracic 
pressures, which were accompanied with signiﬁ  cant dynamic 
airway compression. Whether the reduction of FRC would 
persist beyond a period of laughing was not investigated. 
There is neither another larger study, nor a study in patients 
with respiratory diseases conﬁ  rming these results.
The aim of the current study was to investigate whether 
laughter in response to a humor intervention in patients with 
severe chronic airﬂ  ow obstruction is safe and whether it can 
reduce static lung volumes beyond the period of laughter 
up to 24 hours. We compared the impact of laughter on 
the breathing pattern of patients with severe COPD and 
healthy controls. Furthermore, we observed the impact of 
such a humor intervention on the psychological wellbeing 
and its interaction with breathing pattern and the static lung 
volumes.
Methods
Study population and conduct
For this proof-on-concept intervention trial, 19 patients 
with severe to very severe chronic obstructive lung disease 
(GOLD III and IV) with documented irreversibility and 10 
healthy controls were recruited and were willing to give 
informed consent. All participants were between 20 and 
80 years of age. Healthy controls had to have normal lung 
functions, did not have any chronic disease and were not on 
any regular medication. All patients had to be on a disease 
severity-adapted treatment, and, indeed, all patients were on 
high-dose combined inhalation therapy with long-acting beta-
agonists, topical corticosteroids and thiotropium bromide. 
Some patients additionally had systemic corticosteroids, 
xanthine-derivates and/or long-term oxygen therapy.
Patients with COPD were told to continue their usual 
therapy until the evening before the study day, but withheld 
inhalation therapy during the entire study day. On arrival 
at the lung function laboratory participants underwent a 
baseline assessment including self-administered question-
naires (State-Trait Cheerfulness Inventory developed by 
Ruch and Köhler 1999; Pauwels et al 2001), spirometry and 
plethysmography. They then followed a humor intervention 
in small groups by a clown Pello (Figure 1). Participants were 
exposed to the intervention for a mean duration of 30 (range 
20–60) minutes. During the intervention the participants 
were videotaped for the analysis of response in terms of 
mimic, posture and gesture. The videotapes were analyzed 
by the same psychologist trained in using the Facial Action 
Coding System (Ekman et al 2002) blinded for lung function 
results. Immediately ( 3 minutes), 2, 6, and 24 hours after 
the intervention they underwent a follow-up assessment with 
the self-administered questionnaires and plethysmography. 
The latter did not include any rapid maneuvers to minimize 
potential interaction with the outcome measures. Addition-
ally, patients were equipped with an ambulatory device 
(LifeShirt®, software VivoLogic®; both from VivoMetrix®, 
Ventura/CA, USA; calibration with 800 mL calibration bag) 
able to measure real-time breathing during a baseline resting 
period of 15 minutes, the humor intervention, as well as a 
post-intervention resting period of 15 minutes. The study was 
approved by the local ethical review board (EKBB 24/05).
Assessment of pulmonary function
Measurements of static lung volumes and spirometry were 
done with body plethysmography (Total body master®, 
Jaeger, Würzburg, Germany) and complied with American 
Thoracic Society recommendations (ATS 1991, 1995; Miller 
et al 2005). Diffusion capacity was assessed using a MS-
PFT (Jäger, Würzburg, Germany). A reduction of  10% 
calculated as %-predicted value for the total lung capacity 
(TLC) was considered as biologically meaningful. Therefore, 
individuals with a decrease in TLC of   10%, predicted, were 
taken as “responders”.
Statistical analysis
According to the main hypothesis a change in total lung 
capacity was considered as the main outcome parameter. A 
sample size calculation based on a paired t-test power calcula-
tion showed that, assuming an intra-individual variability for 
TLC of 5%, 17 subjects were necessary to have a power of 
90% in order to detect a mean reduction of 10% in TLC. Data 
analysis was done according to intention-to-treat-principles 
using R (v. 2.2.1, R foundation for statistical computing, 
Vienna, Austria) and SPSS (v. 11, SPSS Inc, USA). Repeated 
measures analyses of variance and student’s T-tests were 
done as appropriate. Signiﬁ  cant variables from the univariate 
comparison between responders and non-responders derived 
from baseline lung functions (TLC at baseline), questionnaires 
(scores for cheerfulness, seriousness and bad mood), and International Journal of COPD 2008:3(1) 187
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Figure 1 The humoristic intervention was done by Pello the clown (panel A), a professional humor consultant experienced with patients affected by chronic diseases. Panel 
B shows a typical scene during the humor intervention. The intervention was done in small groups with roughly 6 participants. Thus, Pello could directly interact with all 
participants and varied his performance in function of individual responses. The show was optimized to induce as much physical laughter as possible. Different accessories like 
puppets, and red plastic noses were used during the intervention, which took place on the hospital ward.
video analysis (intensity of smiling and degrees of laughter) 
were tested for their value as predictors of TLC-response. 
This was tested by multiple linear regression analysis. Data 
are generally presented as mean ± standard deviation. A 
conventional signiﬁ  cance level of 5% was taken.
Results
Demographics
The demographic characteristics of patients and healthy 
controls are given in Table 1. Within healthy control subjects 
there were more females, and they were younger. Thirteen 
of 19 patients had very severe COPD (stage IV according 
to GOLD), 11/19 (58%) had a signiﬁ  cant hyperinﬂ  ation 
(TLC  120%), and all patients had signiﬁ  cant air trapping 
as witnessed by an increased reserve volume (RV).
Safety of humor intervention in patients 
with severe COPD
One patient, hospitalized for an exacerbation of a very severe 
COPD at the time of the study insisted on not applying oxygen 
during the humor intervention. He normally was under long-
term oxygen-therapy. After 10 minutes of intervention he was 
exhausted, required oxygen, and did not want to continue with 
the study. Back in his hospital room he felt well and did not 
experience any discomfort related to the study. The problem 
was probably not a bronchospasm, but the fact that laughing 
led to increased oxygen and ventilatory demands. None of 
the other participants suffered neither from bronchospasm nor 
respiratory discomfort during the whole 24 hours.
Effect of the humor intervention on static 
lung volumes
The intervention led to a reduction of TLC in patients with 
COPD (mean reduction: 0.31 ± 0.54 [−0.36; 1.55] mL, 5 ± 9 
[−6; 24] %, predicted, p = 0.04, (Figure 2), but not in controls 
(mean reduction: 0.24 ± 0.28 [−0.10; 0.58] mL, 5 ± 6 [−2; 13] 
%, predicted, p = 0.9). The effect was rather short-lived 
and no longer present 2 hours after the intervention. The 
responses varied signiﬁ  cantly between subjects. Twenty-two 
(CI 95% 7 to 46) % (4/18) of patients and 20 (CI 95% 4 to 56) 
% (2/10) of healthy individuals reduced their TLC by more 
than 10%, predicted. The reduction of TLC in responders 
ranged between 580 and 1550 mL or 10 and 24%, predicted. 
When analyzing the responders separately the reduction of 
TLC was accompanied by a reduction of the residual volume 
(RV; mean reduction of 992 ± 448 [range 460; 1600] mL, 
33 ± 12%, p   0.001; Figure 3). No change was observed 
for the functional residual capacity (FRC; mean change 
28 ± 850 [range −710–420] mL, −0.8 ± 21%, p = 0.87). The 
vital capacity (VC) did not change signiﬁ  cantly.
Video-analysis and questionnaires 
for the assessment of psychological 
wellbeing
Patients, as well as controls, responded similarly to the humor 
intervention in terms of smiling and laughing (Kruskal-
Wallis p = 0.18). Responders among patients with COPD 
smiled more frequently during the intervention compared 
with nonresponders (p = 0.04).International Journal of COPD 2008:3(1) 188
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The intervention improved cheerfulness in patients 
(p = 0.02) and controls (p = 0.02) without lowering degrees of 
state seriousness and state bad mood (both ns). The changes in 
terms of psychological wellbeing of patients with COPD and 
healthy controls were comparable, but patients with COPD 
had higher degree of seriousness at baseline. The latter might 
also be related to the age difference between patients and 
controls.
Table 1 Characteristics of study participants
Participants Patients  Controls
N 19 10
Demographics  
Sex (m/f)  10/9  2/8
Age [y]*  58 ± 27 (31−84) 32  ± 14 (18−45)
Height [cm]  168 ± 12  166 ± 16
Weight [kg]  72 ± 22  64 ± 16
BMI [kg/m2] 24.1  ± 3.8  22.1 ± 2.4
COPD (Gold I/II/III/IV)  0/0/6/13  NA
Spirometry  
FEV1 [L/sec]*  48 ± 24 (24−72) 105  ± 28 (77−134)
FVC [L]  74 ± 33 (41−108) 109  ± 24 (84−133)
FEV1/FVC 0.38  ± 0.15 (0.23−0.52) 0.80  ± 0.09 (0.71−0.89)
Static lung volumes  
TLC [%, Pred.]  124 ± 47  103 ± 22
TLC  120% [n,%]  11/19 (58%)  1/10 (10%)
ITGV [%, Pred.]  158 ± 53  112 ± 18
RV [%, Pred.]  190 ± 102  102 ± 42
RV/TLC 0.57  ± 0.19  0.29 ± 0.08
Raw [%, Pred.]  472 ± 370  98 ± 39
Diffusion capacity  
TLCO [%, Pred.]  41 ± 15  99 ± 16
KCO [%, Pred.]  38 ± 11  80 ± 10
Notes: *Data presented as mean ± SD (range).
Abbreviations: BMI, body mass index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; KCO, ; RV, 
residual volume; TLC, total lung capacity; TLCO.
Figure 2 Effect of the humoristic intervention on total lung capacity (TLC) over a time period up to 24 hours in patients with COPD (panel A) and healthy controls (panel B). 
Shown are responses as partial residuals of the ﬁ  tted regression model. Responders decreased their TLC for 500 mL to more than 1.55 L, which can be considered as clinically 
relevant. On the other hand, two individuals increased their total lung capacity by roughly 10% or 1 L over time. During the ﬁ  rst 9 hours the patients were not allowed to 
inhale any medication unless used as a rescue medication (which did not occur). This might explain why some individuals increased their TLC.
*Signiﬁ  cant number of missing values for healthy controls at 24 h.
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Figure 3 Comparison of the change in static lung volumes between baseline and time 0 hour after the humor intervention in TLC-responders compared to non-responders. 
Reduction of TLC in responders in response to the humor intervention was primarily due to a reduction of the reserve volume (RV). The functional residual capacity (FRC) 
and the vital capacity did not change signiﬁ  cantly.
Independent predictors of TLC-response
Multiple linear regression analysis was used in an explor-
atory fashion to identify independent predictors of response. 
The frequency of smiling (p = 0.018) and TLC at baseline 
(p = 0.021) proved to be the only independent predictors of 
TLC-response.
Analysis of real-time breathing pattern
During the intervention and in order to adapt for a 
higher demand in oxygen uptake and minute ventila-
tion in response to physical activity and emotion, 
patients mainly increased their breathing frequency, 
whereas controls increased their tidal volumes (Table 2). 
Representative examples of responses to laughter are 
shown in Figure 4.
Discussion
A humor intervention with a clown triggering laughter is safe 
even in patients with severe and very severe COPD and was 
able to reduce hyperinﬂ  ation. In 22% of patients with COPD 
and 20% of healthy controls the decrease of TLC was  10% 
and up to 1.55 L. The reduction of TLC was associated with 
a similar decrease in the reserve volume indicating that the 
intervention was able to reduce air trapping. Functional 
residual capacity remained unchanged. Not unexpectedly, 
but also of potential importance for well-being and quality 
of life, the humor intervention improved state cheerfulness, 
but not state seriousness and state bad mood of patients and 
controls. The frequency of smiling and TLC at baseline were 
independent predictors of TLC-response. Intense laughter 
rather increased the dynamic hyperinflation in patients International Journal of COPD 2008:3(1) 190
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Table 2 Results of real-time breathing pattern during the humor intervention
   COPD      Controls    Sig.
   (n  = 11)      (n = 9)
 Pre  Clown  Post  Pre  Clown  Post 
Breathing rate [bpm]  22 ± 6*  27 ± 6  23 ± 8  17 ± 4*  26 ± 8  18 ± 3 
Tidal volume [mL]  430 ± 103 510  ± 155  433 ± 129  423 ± 108  578 ± 164  386 ± 130  0.05†
Minute   8.9 ± 3.2* 12.7  ± 1.5 9.3  ± 2.8  6.5 ± 1.1*  14.3 ± 2.9  6.2 ± 1.8  0.10†
ventilation [L/min]             
I-E ratio  0.66 ± 0.12  0.87 ± 0.17  0.70 ± 0.17  0.68 ± 0.13  1.09 ± 0.09  0.70 ± 0.09  0.03†
Phase angle [°]  12.1 ± 6.3*  22.6 ± 7.2  14.8 ± 6.5  4.9 ± 1.9*  15.6 ± 5.2  5.0 ± 1.6  0.003†
Vt irregularity index  0.16 ± 0.04*  0.21 ± 0.04  0.18 ± 0.06  0.13 ± 0.03*  0.21 ± 0.06  0.14 ± 0.03 
Notes: *Baseline differences between groups (p   0.05).
†Signiﬁ  cance of interaction between COPD and controls over time.
°Phase angle between abdominal and ribcage changes.
Figure 4 Spirogram from the real-time monitoring of the breathing pattern showing the varying instant effect of laughter on the end-expiratory lung volume (EELV) in patients 
with COPD. Intense laughter can lead to dynamic hyperinﬂ  ation in some patients with severe COPD (panel A). Most of the times there was no signiﬁ  cant change in the EELV 
due to a single ﬁ  t of laughter (panel B). In some instances, particularly as a consequence of smiling, the EELV markedly diminished (panel C). Smiling was able to reduce the 
EELV in both COPD and controls – at least as an instant effect.
B. Moderate laughter reduces EELV only during laughter (no change)
C. Moderate laughter reduces EELV beyond laughter in COPD
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with severe COPD probably due to the increased minute 
ventilation and the higher breathing rate on the expense of 
a shorter expiration time (O’Donnell et al 2001; Gelb et al 
2004; Calverley 2006).
The nonrandomized fashion and the lack of cross-
over design represent limitations of this study, which was 
conceived as a proof-of-concept study. However, the main 
ﬁ  nding – the fact that gentle laughter and smiling can reduce 
total lung volume – is also backed up with the real-time 
analysis of the breathing pattern during the intervention. The 
humor intervention with a clown represents a nonstandardized 
procedure when compared with individual laboratory 
manipulations, eg, employing a humorous videotape. On 
the other hand, the clown could directly interact with each 
individual in order to optimize the likelihood of subjects 
laughing as much as possible. This could prevent the possibility 
that some individuals would not laugh at all, as might be the 
case during a more standardized intervention. Therefore, the 
lack of a strict standardization might even represent strength 
and not a weakness of this trial. Also, smiling/laughter and 
psychological responses were taken as quantitative variables 
when analyzing the response patterns.
What happens exactly to the lung mechanics during 
smiling and laughter? Derived from the analysis of real-
time breathing pattern during the intervention smiling and 
laughter can start at any point of a normal tidal volume 
breathing cycle. The start is characterized by an abrupt 
expiratory effort, which is followed by ﬁ  ts of expiratory 
saccades of variable length. During these periods the end-
expiratory lung volume is typically diminished compared to 
tidal breathing. Short, but often rapid and efﬁ  cient inspira-
tions occur between expiratory saccades. During smiling 
and laughter expiration is prolonged compared to inspira-
tion. But, what might make the difference between smiling 
and laughter? The differences are two-fold: vocalization 
leading to higher positive airway pressures, and activation 
of additional muscles groups translating to an increased 
ventilatory demand and oxygen consumption (O’Donnell 
2001; Ruch and Ekman 2001). In contrast to laughing, 
smiling consists of a mostly passive maneuver including 
low-level rhythmic contractions of abdominal muscles, 
relaxation of the diaphragm, prolonged expiration, neither 
of which should produce signiﬁ  cantly increased ventilation 
nor oxygen consumption. For higher intensities of laughter, 
there is an increased demand for ventilation and oxygen 
consumption. Increased minute ventilation is known to lead 
to an increase of the dynamic hyperinﬂ  ation of patients with 
COPD (O’Donnell 2001; Gelb et al 2004).
In conclusion, a humor intervention was able to reduce 
hyperinﬂ  ation in patients with severe and very severe COPD. 
Response was mainly associated with smiling and a higher 
degree of hyperinﬂ  ation. The results of this proof-of-concept 
study need to be validated by a randomized cross-over study, 
especially for a more reliable appreciation of the effect size and 
duration. If conﬁ  rmed, a smiling-derived breathing technique 
could complement the technique of pursed-lips breathing, and 
enrich the repertoire of patients with symptomatic airway 
obstruction to better cope with breathlessness (Gosselink 
2004). Furthermore this could be achieved anywhere and at 
any time at no costs and with no drug-induced side effects. On 
the other hand, therapeutic approaches combining breathing 
technique with an emotional intervention might be preferable 
and more likely to be effective.
“Give COPD patients a smile!”
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